Page 5 - Breakthrough Device News Today

Fractyl Health, Inc., in a filing with the U.S. Securities and Exchange Commission, on Monday said it expects to price the initial public offering or IPO of 7.33 million shares to be between $14.

FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural...

Osteoboost is the first and only non-pharmacological prescription treatment to demonstrate reduced loss of bone strength in postmenopausal womenRepresents the first therapeutic mechanism specifically designed and cleared for intervention during the osteopenia stageREDWOOD CITY, CA / ACCESSWIRE / January 18, 2024 / B...

/PRNewswire/ -- In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin...

WATERTOWN, Mass., Jan. 12, 2024 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are...

New codes and payment expected to facilitate clinical adoption of novel cancer treatment option

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

Postmenopausal women have a dizzying array of pills, inserts and devices to amp up their sex lives these days, as money finally flows for women's sexual health solutions. But is sex actually getting any better? Are we anywhere closer to a Viagara-like game-changer that will usher in a new frontier of female pleasure for older women?  

The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.